NEW RULES FOR NEW DRUGS - THE CHALLENGE OF AIDS TO THE REGULATORY PROCESS

被引：47

作者：

EDGAR, H ^{[1
]}

ROTHMAN, DJ ^{[1
]}

机构：

[1] COLUMBIA UNIV COLL PHYS & SURG,CTR STUDY SOC & MED,630 W 168TH ST,ROOM 138,BLACK BLDG,NEW YORK,NY 10032

来源：

关键词：

D O I：

10.2307/3350178

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

[No abstract available]

引用

页码：111 / 142

页数：32

共 27 条

[1]

*AIDS COAL UNL POW, 1989, 5TH INT C AIDS

[2] ETHICS AND CLINICAL RESEARCH [J].

BEECHER, HK .

[3]

BOFFEY PM, 1988, NY TIMES 0802

[4] THE CASE FOR PATIENT ACCESS TO EXPERIMENTAL-THERAPY [J].

DELANEY, M .

DUBLER, NN ;

SIDEL, VW .

[6]

EIGO J, 1988, UNPUB FDA ACTION HDB

[7]

Faden R.R., 1986, HIST THEORY INFORMED

[8]

FRANKEL MS, 1973, MONOGRAPH G WASHINGT, V10

[9] THE REGULATION OF INVESTIGATIONAL DRUGS [J].

KESSLER, DA .

[10] PSYCHOTROPIC DRUGS AS THERAPEUTIC AGENTS [J].

KLERMAN, GL .

HASTINGS CENTER STUDIES, 1974, 2 (01) :81-93